SIMPLIFYING PROGRESS

Serial Number 88797765
606

Registration Progress

Application Filed
Feb 14, 2020
Under Examination
Mar 2, 2021
Approved for Publication
Jan 5, 2021
Published for Opposition
Jan 5, 2021
Registered

Trademark Image

SIMPLIFYING PROGRESS

Basic Information

Serial Number
88797765
Filing Date
February 14, 2020
Published for Opposition
January 5, 2021
Abandonment Date
April 8, 2024
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Apr 8, 2024
Classes
042

Rights Holder

Sartorius AG

99
Address
Otto-Brenner-Straße 20
Göttingen 37079
DE

Ownership History

Sartorius AG

Original Applicant
99
Göttingen DE

Sartorius AG

Owner at Publication
99
Göttingen DE

Legal Representation

Attorney
Megan E. Spitz

USPTO Deadlines

All Deadlines Cleared

All 5 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

37 events
Date Code Type Description Documents
Apr 8, 2024 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Apr 8, 2024 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Jul 27, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jul 26, 2023 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Jul 26, 2023 EX5G S SOU EXTENSION 5 GRANTED Loading...
Jul 19, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 19, 2023 EXT5 S SOU EXTENSION 5 FILED Loading...
Mar 2, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Feb 28, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Feb 28, 2023 EXT4 S SOU EXTENSION 4 FILED Loading...
Feb 28, 2023 EX4G S SOU EXTENSION 4 GRANTED Loading...
Aug 10, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Aug 8, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Aug 8, 2022 EXT3 S SOU EXTENSION 3 FILED Loading...
Aug 8, 2022 EX3G S SOU EXTENSION 3 GRANTED Loading...
Feb 18, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Feb 16, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Feb 16, 2022 EXT2 S SOU EXTENSION 2 FILED Loading...
Feb 16, 2022 EX2G S SOU EXTENSION 2 GRANTED Loading...
Aug 31, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Aug 27, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Aug 27, 2021 EXT1 S SOU EXTENSION 1 FILED Loading...
Aug 27, 2021 EX1G S SOU EXTENSION 1 GRANTED Loading...
Mar 2, 2021 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jan 5, 2021 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jan 5, 2021 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Dec 16, 2020 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Dec 3, 2020 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Nov 12, 2020 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Nov 12, 2020 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Nov 12, 2020 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
May 14, 2020 CNRT R NON-FINAL ACTION WRITTEN Loading...
May 14, 2020 GNRT F NON-FINAL ACTION E-MAILED Loading...
May 14, 2020 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
May 6, 2020 DOCK D ASSIGNED TO EXAMINER Loading...
Feb 20, 2020 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Feb 18, 2020 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Scientific laboratory services; calibration services for test medium supervision; calibration of pipettes; calibration of measuring apparatus in the context of legal metrology; testing services, namely, conducting tests for the validation of filter systems, bioreactors and fermenters and biosensors in the context of quality control for manufacturers of pharmaceutical products; conducting integrity tests for filter installation in the nature of quality control for others; quality control testing of cell banks, virus banks, raw materials of animal origin, bulk harvest and clinical batches regarding contamination with bacteria, fungi, yeasts, mycoplasma, adventitious viruses and any other potential contaminants; advisory and consultancy services relating to the aforementioned scientific laboratory, testing, calibration and quality control services; development of scientific and technical processes for the production of proteins; performing biological and chemical analysis of amino acids in protein samples; biological and chemical laboratory services, namely, scientific support of production processes relating to biological preparations and pharmaceuticals; scientific and technological services and research and design in the fields of chemistry, biochemistry, biology, bacteriology, pharmaceuticals, biotechnology and vaccines, namely, product characterization and release testing, cell based potency assays, virus screening assays, molecular biology and protein characterization, batch release testing, batch release testing with recombinant proteins, monoclonal antibodies, fusion proteins, gene therapy vectors, virus vaccines and cell based therapies, supporting assays for clinical trial analysis, antidrug antibody determination and residual DNA, development and release of vaccine and biologic products, and clinical research services, namely, collection, calibration and reporting of data in connection with clinical trials of pharmaceuticals; biosafety testing services for testing and product development of biologic products, vaccines, medicinal herbal products and complementary and alternative medicines; biosafety product, laboratory and manufacturing process testing services for the pharmaceutical, biotech and vaccine sectors; chemical, biochemical, biological and bacteriological analysis and research services; computer programming; consultancy relating to computer network design; system consultancy, namely, computer system analysis, filter system analysis and bioreactor analysis and consultancy relating to creating and changing the scale of systems consisting of computer, filter and bioreactor installations taking into consideration the mutual compatibility of these installations; technical verification and validation concepts, namely, testing, analysis and evaluation of the goods, manufacturing facilities and manufacturing processes of others to determine conformity with certification standards in particular for the pharmaceutical industry and for the food and drink industry; audits not for business purposes, namely, technical monitoring of the conformity of products, installations and methods using regulatory and legal specifications and guidelines for technical evaluation purposes; technical consultancy related to providing technical support for manufacturers of pharmaceutical products and for food and drink producers during audits, namely, during monitoring of the technological conformity of products, installations and methods using regulatory and legal specifications and guidelines related only to the technological aspects in the aforementioned fields; software development; software installation; software consultancy services, namely, consulting services in the field of selection, implementation, and use of computer software systems of others, business technology software consultation services, consulting services in the field of software as a services; computer software maintenance; computer software technical support services, namely installation of industrial process and laboratory equipment control computer software, troubleshooting of industrial process and laboratory equipment control computer software problems, troubleshooting in the nature of diagnosing computer software problems; biological research and analysis; chemical research and analysis, medical research; development of processes for the production of proteins, namely, process design, engineering, research in the field of protein production; product research and development cell line development; consultancy with regard to the technical development of scientific processes for the production of proteins and the development of cell lines; cell line and cell bank manufacturing; biological analysis being biosimilar analysis and testing services to determine product quality, product safety, conformity with certification standards; cell bank characterization in the nature of testing and analyzing cell banks for their compliance with safety and quality standards; providing information, advisory and consultancy services relating to the aforementioned services
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
042